INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
BIT:1ISRG - Euronext Milan - US46120E6023 - Common Stock - Currency: EUR
Taking everything into account, 1ISRG scores 6 out of 10 in our fundamental rating. 1ISRG was compared to 53 industry peers in the Health Care Equipment & Supplies industry. 1ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. 1ISRG shows excellent growth, but is valued quite expensive already. This makes 1ISRG very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
1ISRG had positive earnings in the past year.
1ISRG had a positive operating cash flow in the past year.
In the past 5 years 1ISRG has always been profitable.
Each year in the past 5 years 1ISRG had a positive operating cash flow.
1.2 Ratios
1ISRG's Return On Assets of 12.39% is amongst the best of the industry. 1ISRG outperforms 90.57% of its industry peers.
The Return On Equity of 1ISRG (14.05%) is better than 86.79% of its industry peers.
The Return On Invested Capital of 1ISRG (10.67%) is better than 88.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for 1ISRG is in line with the industry average of 8.25%.
The 3 year average ROIC (10.24%) for 1ISRG is below the current ROIC(10.67%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.39% | ||
| ROE | 14.05% | ||
| ROIC | 10.67% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
1.3 Margins
The Profit Margin of 1ISRG (27.81%) is better than 94.34% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG has a better Operating Margin (28.14%) than 100.00% of its industry peers.
1ISRG's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 67.46%, 1ISRG is doing good in the industry, outperforming 69.81% of the companies in the same industry.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.14% | ||
| PM (TTM) | 27.81% | ||
| GM | 67.46% |
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so 1ISRG is still creating some value.
1ISRG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.18
WACC9.07%
2.3 Liquidity
1ISRG has a Current Ratio of 5.22. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
1ISRG's Current ratio of 5.22 is amongst the best of the industry. 1ISRG outperforms 96.23% of its industry peers.
A Quick Ratio of 4.54 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG has a better Quick ratio (4.54) than 98.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.22 | ||
| Quick Ratio | 4.54 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 27.76% over the past year.
Measured over the past years, 1ISRG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.48% on average per year.
Looking at the last year, 1ISRG shows a quite strong growth in Revenue. The Revenue has grown by 19.08% in the last year.
Measured over the past years, 1ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
3.2 Future
Based on estimates for the next years, 1ISRG will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.44% on average per year.
1ISRG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.47% yearly.
EPS Next Y12.08%
EPS Next 2Y14.65%
EPS Next 3Y14.94%
EPS Next 5Y14.44%
Revenue Next Year17.84%
Revenue Next 2Y16.64%
Revenue Next 3Y16.07%
Revenue Next 5Y13.47%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 71.43, 1ISRG can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as 1ISRG.
When comparing the Price/Earnings ratio of 1ISRG to the average of the S&P500 Index (24.21), we can say 1ISRG is valued expensively.
With a Price/Forward Earnings ratio of 56.67, 1ISRG can be considered very expensive at the moment.
1ISRG's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, 1ISRG is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 71.43 | ||
| Fwd PE | 56.67 |
4.2 Price Multiples
1ISRG's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1ISRG is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 150.03 | ||
| EV/EBITDA | 58.83 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of 1ISRG may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 14.94% in the coming years.
PEG (NY)5.91
PEG (5Y)6.22
EPS Next 2Y14.65%
EPS Next 3Y14.94%
5. Dividend
5.1 Amount
No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (5/8/2025, 7:00:00 PM)
480.75
+45.55 (+10.47%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners89.44%
Inst Owner ChangeN/A
Ins Owners0.5%
Ins Owner ChangeN/A
Market Cap172.24B
Analysts79.49
Price Target513.63 (6.84%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.57%
Min EPS beat(2)10.37%
Max EPS beat(2)20.76%
EPS beat(4)4
Avg EPS beat(4)12.24%
Min EPS beat(4)4.44%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)7.68%
EPS beat(12)10
Avg EPS beat(12)4.92%
EPS beat(16)13
Avg EPS beat(16)7.19%
Revenue beat(2)1
Avg Revenue beat(2)2.49%
Min Revenue beat(2)-0.14%
Max Revenue beat(2)5.12%
Revenue beat(4)1
Avg Revenue beat(4)1.04%
Min Revenue beat(4)-0.76%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)0.53%
Revenue beat(12)5
Avg Revenue beat(12)0%
Revenue beat(16)7
Avg Revenue beat(16)1.66%
PT rev (1m)-17.24%
PT rev (3m)-8.79%
EPS NQ rev (1m)-0.97%
EPS NQ rev (3m)-3.06%
EPS NY rev (1m)0.04%
EPS NY rev (3m)2.35%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.49%
Revenue NY rev (1m)0.48%
Revenue NY rev (3m)1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 71.43 | ||
| Fwd PE | 56.67 | ||
| P/S | 23.42 | ||
| P/FCF | 150.03 | ||
| P/OCF | 81 | ||
| P/B | 11.83 | ||
| P/tB | 12.09 | ||
| EV/EBITDA | 58.83 |
EPS(TTM)6.73
EY1.4%
EPS(NY)8.48
Fwd EY1.76%
FCF(TTM)3.2
FCFY0.67%
OCF(TTM)5.94
OCFY1.23%
SpS20.53
BVpS40.62
TBVpS39.77
PEG (NY)5.91
PEG (5Y)6.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.39% | ||
| ROE | 14.05% | ||
| ROCE | 14.22% | ||
| ROIC | 10.67% | ||
| ROICexc | 22.9% | ||
| ROICexgc | 23.99% | ||
| OM | 28.14% | ||
| PM (TTM) | 27.81% | ||
| GM | 67.46% | ||
| FCFM | 15.61% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.18%
ROE(5y)12.95%
ROIC(3y)10.24%
ROIC(5y)9.93%
ROICexc(3y)18.39%
ROICexc(5y)17.67%
ROICexgc(3y)19.32%
ROICexgc(5y)18.71%
ROCE(3y)13.65%
ROCE(5y)13.23%
ROICexcg growth 3Y10.09%
ROICexcg growth 5Y3.3%
ROICexc growth 3Y10.33%
ROICexc growth 5Y3.99%
OM growth 3Y-4.3%
OM growth 5Y-1.74%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score7
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 222.37% | ||
| Cap/Sales | 13.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 84.73% | ||
| Profit Quality | 56.14% | ||
| Current Ratio | 5.22 | ||
| Quick Ratio | 4.54 | ||
| Altman-Z | N/A |
F-Score7
WACC9.07%
ROIC/WACC1.18
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)27.76%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%20.67%
EPS Next Y12.08%
EPS Next 2Y14.65%
EPS Next 3Y14.94%
EPS Next 5Y14.44%
Revenue 1Y (TTM)19.08%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%19.19%
Revenue Next Year17.84%
Revenue Next 2Y16.64%
Revenue Next 3Y16.07%
Revenue Next 5Y13.47%
EBIT growth 1Y32.03%
EBIT growth 3Y8.64%
EBIT growth 5Y11.3%
EBIT Next Year37.77%
EBIT Next 3Y23.18%
EBIT Next 5Y19.91%
FCF growth 1Y73.93%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y33.15%
OCF growth 3Y4.95%
OCF growth 5Y8.61%